PELNSEPiramal Enterprises Limited· PharmaceuticalsHighNeutral
Announced Sat, 5 Jul · 14:07 IST

Piramal Enterprises Limited has submitted the Exchange a copy Srutinizers report along with voting results of NCLT Convened Meeting of Equity shareholders held on July 04, 2025

Nclt Scheme FiledStrategic Transactions View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Piramal Enterprises held an NCLT-ordered meeting of equity shareholders on July 4, 2025, to vote on a composite scheme of arrangement involving the company, Piramal Finance Limited (formerly Piramal Capital & Housing Finance Limited), and their respective shareholders and creditors. Shareholders approved the scheme with an overwhelming 99.9975% majority — roughly 15.9 crore votes in favor compared to just 3,980 against. Both the promoter group and public institutional investors voted 100% in favor of the resolution. Around 70.16% of total outstanding shares participated in the voting, and the Scrutinizer has confirmed the results as valid.

Likely market impact

The near-unanimous shareholder approval is a key milestone for the composite scheme, clearing one of the major procedural hurdles. The scheme still requires further NCLT sanction and regulatory clearances before it can take effect, but the strong vote reduces the risk of delays. For shareholders, this signals management's ability to push the restructuring forward smoothly.